Your browser doesn't support javascript.
loading
Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction: an updated systematic review and network meta-analysis of randomized controlled trials.
Lin, Yaowang; Cai, Zhigang; Yuan, Jie; Liu, Huadong; Pang, Xinli; Chen, Qiuling; Tang, Xinzheng; Geng, Qingshan; Dong, Shaohong.
Afiliación
  • Lin Y; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
  • Cai Z; Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen, 518000, People's Republic of China.
  • Yuan J; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
  • Liu H; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
  • Pang X; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
  • Chen Q; Department of Pharmacy, Shenzhen People's Hospital, Shenzhen, People's Republic of China.
  • Tang X; Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen, 518000, People's Republic of China. xnktangxinzheng@yeah.net.
  • Geng Q; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
  • Dong S; Department of Geriatrics, Shenzhen People's Hospital, Shenzhen, People's Republic of China. szgengqingshan@yeah.net.
Cardiovasc Diabetol ; 21(1): 237, 2022 11 08.
Article en En | MEDLINE | ID: mdl-36348348
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article